Search Results 1681-1690 of 8633 for Tetracycline ointment

  1. Ocrelizumab and hyaluronidase-ocsq (subcutaneous route) - Side effects & uses - Mayo Clinic

    Ocrelizumab and hyaluronidase-ocsq combination injection is used to treat the relapsing forms (including clinically isolated syndrome, relapsing-remitting ...

  2. Ertapenem (injection route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  3. Publications - Michael B. Phillips, M.D. - Mayo Clinic

    Decosma L, Phillips MB. Paraneoplastic hypercalcemia and other electrolyte abnormalities in localized ameloblastoma. Annals of Internal Medicine Clinical ...

  4. Omalizumab-igec (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Omalizumab-igec injection is used to treat moderate to severe persistent allergic asthma. It is used when a patient's asthma has not been controlled ...

  5. Publications - John P. Sweeney, M.D. - Mayo Clinic

    Elshaer A, Habib E, Ibrahim R, Elsayed AM, Hewitt WR, Mathur AK, Alsidawi S, Sweeney JP, Fortuin FD, Carey EJ, Steidley DE. Urgent transcatheter tricuspid ...

  6. Lacosamide (oral route) - Side effects & dosage - Mayo Clinic

    Description. Lacosamide is used to treat partial-onset seizures. It is also used with other medicines to treat primary generalized tonic-clonic seizures.

  7. Odevixibat (oral route) - Side effects & dosage - Mayo Clinic

    Odevixibat is used to treat pruritus (skin itching) in patients with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS). This ...

  8. Nifurtimox (oral route) - Side effects & dosage - Mayo Clinic

    Nifurtimox is used to treat Chagas disease (American Trypanosomiasis) in children. Chagas disease is a potentially life-threatening disease caused by the ...

  9. Dermatology Genetics Clinic - Overview

    Albinism. · Birthmarks. · Carney complex. · Cowden syndrome. · Cutaneous mosaicism. · Cutis laxa. · Dyskeratosis congenita. · Ectodermal dysplasia.

  10. Multiple Myeloma Clinical Trials - Mayo Clinic Research

    The primary objectgive of this study is to determine the effectiveness of SAR442168 compared to placebo in delaying disability progression in primary ...